Revolution Medicines, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Revolution Medicines, Inc. now
Current reporting with the operating signal separated from the noise.
Revolution Medicines, Inc.: European Medicines Agency Expedites Assessment of Revolution Medicines' Daraxonrasib Under Phased Review Process
The story matters when it changes Revolution Medicines, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Revolution Medicines, Inc. (RVMD) Discusses Positive Clinical Results and Implications for Metastatic Pancreatic Cancer Treatment Transcript
The story matters when it changes Revolution Medicines, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes
Investors are testing whether Revolution Medicines, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Is Revolution Medicines, Inc. (RVMD) A Good Stock To Buy Now?
Investors are testing whether Revolution Medicines, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Revolution Medicines, Inc. (RVMD) Q3 2025 Earnings Call Transcript
Investors are testing whether Revolution Medicines, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest RVMD filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Revolution Medicines, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →